Circulating tumor DNA laboratory processes and clinical applications in nasopharyngeal carcinoma
Circulating tumor DNA (ctDNA), a subset of cell-free DNA (cfDNA), originates from primary tumors and metastatic lesions in cancer patients, often carrying genomic variations identical to those of the primary tumor. ctDNA analysis via liquid biopsy has proven to be a valuable biomarker for early canc...
Saved in:
| Main Authors: | Ziman Wu, Haiyan Yang, Xinying Li, Xiang Ji, Chan Mo, Zhou Zheng, Yafei Xu, Dan Xiong |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-05-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1520733/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
KYNU is a potential metabolic-related biomarker for nasopharyngeal carcinoma by Raman spectroscopy, metabolomics, and transcriptomics analysis
by: Ziman Wu, et al.
Published: (2025-08-01) -
Research trends and prospects of Circulating tumor DNA associated with colorectal cancer: a bibliometric analysis
by: Shusen Xia, et al.
Published: (2025-08-01) -
Bibliometric analysis of global research trends and prospects on circulating tumor DNA in colorectal cancer
by: Jing Pang, et al.
Published: (2024-11-01) -
The effect of circulating tumor DNA on the prognosis of patients with head and neck squamous cell carcinoma: a systematic review and meta-analysis
by: Ruoyi Yang, et al.
Published: (2024-11-01) -
Real-World Validity of Tissue-Agnostic Circulating Tumor DNA Response Monitoring in Lung Cancers Treated With Chemotherapy, Immunotherapy, or Targeted Agents
by: Anne C. Chiang, MD, PhD, et al.
Published: (2025-09-01)